ETODOLAC- etodolac tablet, film coated Vereinigte Staaten - Englisch - NLM (National Library of Medicine)

etodolac- etodolac tablet, film coated

lake erie medical dba quality care products llc - etodolac (unii: 2m36281008) (etodolac - unii:2m36281008) - carefully consider the potential benefits and risks of etodolac tablets and other treatment options before deciding to use etodolac tablets. use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see warnings ). etodolac tablets are indicated: - for acute and long-term use in the management of signs and symptoms of the following: 1. osteoarthritis 2. rheumatoid arthritis - for the management of acute pain etodolac tablets are contraindicated in patients with known hypersensitivity to etodolac or other ingredients in etodolac tablets. etodolac tablets should not be given to patients who have experienced asthma, urticaria, or other allergic-type reactions after taking aspirin or other nsaids. severe, rarely fatal, anaphylactic-like reactions to nsaids have been reported in such patients (see warnings , anaphylactoid reactions and precautions , preexisting asthma). etodolac tablets are contraindicated for the

TOLMETIN SODIUM tablet, film coated Vereinigte Staaten - Englisch - NLM (National Library of Medicine)

tolmetin sodium tablet, film coated

stat rx usa llc - tolmetin sodium (unii: 02n1tzf99f) (tolmetin - unii:d8k2jpn18b) - tolmetin sodium 600 mg - carefully consider the potential benefits and risks of tolmetin sodium tablets and other treatment options before deciding to use tolmetin sodium tablets. use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see warnings). tolmetin sodium tablets are indicated for the relief of signs and symptoms of rheumatoid arthritis and osteoarthritis. tolmetin is indicated in the treatment of acute flares and the long-term management of the chronic disease. tolmetin is also indicated for treatment of juvenile rheumatoid arthritis. the safety and effectiveness of tolmetin have not been established in pediatric patients under 2 years of age (see precautions: pediatric use and dosage and administration). tolmetin is contraindicated in patients with known hypersensitivity to tolmetin sodium. tolmetin should not be given to patients who have experienced asthma, urticaria or allergic-type reactions after taking aspirin or other nsaids. severe, rarely fatal, anaph

NAPROXEN SODIUM tablet Vereinigte Staaten - Englisch - NLM (National Library of Medicine)

naproxen sodium tablet

nucare pharmaceuticals, inc. - naproxen sodium (unii: 9tn87s3a3c) (naproxen - unii:57y76r9atq) - carefully consider the potential benefits and risks of naproxen sodium tablets, usp and other treatment options before deciding to use naproxen sodium tablets, usp. use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see warnings ). naproxen, usp as naproxen sodium tablets, usp are indicated: - for the relief of the signs and symptoms of rheumatoid arthritis - for the relief of the signs and symptoms of osteoarthritis - for the relief of the signs and symptoms of ankylosing spondylitis - for the relief of the signs and symptoms of juvenile arthritis - for relief of the signs and symptoms of tendonitis - for relief of the signs and symptoms of bursitis - for relief of the signs and symptoms of acute gout - for the management of pain - for the management of primary dysmenorrhea naproxen sodium tablets, usp are contraindicated in patients with known hypersensitivity to naproxen, usp and naproxen sodium, usp. naproxen sodium, usp should not be g

ARTHROTEC- diclofenac sodium and misoprostol tablet, film coated Vereinigte Staaten - Englisch - NLM (National Library of Medicine)

arthrotec- diclofenac sodium and misoprostol tablet, film coated

rebel distributors corp. - diclofenac sodium (unii: qtg126297q) (diclofenac - unii:144o8ql0l1), misoprostol (unii: 0e43v0bb57) (misoprostol - unii:0e43v0bb57) - diclofenac sodium 75 mg - carefully consider the potential benefits and risks of arthrotec and other treatment options before deciding to use arthrotec. use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see warnings ). arthrotec is indicated for treatment of the signs and symptoms of osteoarthritis or rheumatoid arthritis in patients at high risk of developing nsaid-induced gastric and duodenal ulcers and their complications. see warnings, gastrointestinal effects - risk of ulceration, bleeding and perforation for a list of factors that may increase the risk of nsaid-induced gastric and duodenal ulcers and their complications. see boxed contraindications and warnings related to misoprostol. arthrotec should not be taken by pregnant women. arthrotec is contraindicated in patients with hypersensitivity to diclofenac or to misoprostol or other prostaglandins. arthrotec should not be given to patients who have experienced asthma, urticaria, or other allergic-type reactions after

KETOROLAC TROMETHAMINE tablet, film coated Vereinigte Staaten - Englisch - NLM (National Library of Medicine)

ketorolac tromethamine tablet, film coated

carilion materials management - ketorolac tromethamine (unii: 4eve5946bq) (ketorolac - unii:yzi5105v0l) - ketorolac tromethamine 10 mg - carefully consider the potential benefits and risks of ketorolac tromethamine tablets usp and other treatment options before deciding to use ketorolac tromethamine tablets usp. use the lowest effective dose for the shortest duration consistent with individual patient treatment goals. ketorolac tromethamine tablets usp are indicated for the short-term (≤ 5 days) management of moderately severe acute pain that requires analgesia at the opioid level, usually in a postoperative setting. therapy should always be initiated with iv or im dosing of ketorolac tromethamine and ketorolac tromethamine tablets usp are to be used only as continuation treatment, if necessary. the total combined duration of use of ketorolac tromethamine tablets usp and ketorolac tromethamine is not to exceed 5 days of use because of the potential of increasing the frequency and severity of adverse reactions associated with the recommended doses (see , , , and ). patients should be switched to alternative analgesics as soon as possible, but k

ARTHROTEC- diclofenac sodium and misoprostol tablet, film coated Vereinigte Staaten - Englisch - NLM (National Library of Medicine)

arthrotec- diclofenac sodium and misoprostol tablet, film coated

stat rx usa llc - diclofenac sodium (unii: qtg126297q) (diclofenac - unii:144o8ql0l1), misoprostol (unii: 0e43v0bb57) (misoprostol - unii:0e43v0bb57) - diclofenac sodium 75 mg - carefully consider the potential benefits and risks of arthrotec and other treatment options before deciding to use arthrotec. use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see warnings ). arthrotec is indicated for treatment of the signs and symptoms of osteoarthritis or rheumatoid arthritis in patients at high risk of developing nsaid-induced gastric and duodenal ulcers and their complications. see warnings, gastrointestinal effects - risk of ulceration, bleeding, and perforation for a list of factors that may increase the risk of nsaid-induced gastric and duodenal ulcers and their complications. see boxed contraindications and warnings related to misoprostol. arthrotec should not be taken by pregnant women. arthrotec is contraindicated in patients with hypersensitivity to diclofenac or to misoprostol or other prostaglandins. arthrotec should not be given to patients who have experienced asthma, urticaria, or other allergic-type reactions after

ARTHROTEC- diclofenac sodium and misoprostol tablet, film coated Vereinigte Staaten - Englisch - NLM (National Library of Medicine)

arthrotec- diclofenac sodium and misoprostol tablet, film coated

physicians total care, inc. - diclofenac sodium (unii: qtg126297q) (diclofenac - unii:144o8ql0l1), misoprostol (unii: 0e43v0bb57) (misoprostol - unii:0e43v0bb57) - diclofenac sodium 50 mg - carefully consider the potential benefits and risks of arthrotec and other treatment options before deciding to use arthrotec. use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see warnings ). arthrotec is indicated for treatment of the signs and symptoms of osteoarthritis or rheumatoid arthritis in patients at high risk of developing nsaid-induced gastric and duodenal ulcers and their complications. see warnings, gastrointestinal effects - risk of ulceration, bleeding, and perforation for a list of factors that may increase the risk of nsaid-induced gastric and duodenal ulcers and their complications. see boxed contraindications and warnings related to misoprostol. arthrotec should not be taken by pregnant women. arthrotec is contraindicated in patients with hypersensitivity to diclofenac or to misoprostol or other prostaglandins. arthrotec should not be given to patients who have experienced asthma, urticaria, or other allergic-type reactions after

IBUPROFEN tablet Vereinigte Staaten - Englisch - NLM (National Library of Medicine)

ibuprofen tablet

rxchange co. - ibuprofen (unii: wk2xyi10qm) (ibuprofen - unii:wk2xyi10qm) - ibuprofen 600 mg - carefully consider the potential benefits and risks of ibuprofen tablets and other treatment options before deciding to use ibuprofen tablets. use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see warnings ). ibuprofen tablets are indicated for relief of the signs and symptoms of rheumatoid arthritis and osteoarthritis. ibuprofen tablets are indicated for relief of mild to moderate pain. ibuprofen tablets are also indicated for the treatment of primary dysmenorrhea. controlled clinical trials to establish the safety and effectiveness of ibuprofen tablets in children have not been conducted. ibuprofen tablets are contraindicated in patients with known hypersensitivity to ibuprofen. ibuprofen tablets should not be given to patients who have experienced asthma, urticaria, or allergic-type reactions after taking aspirin or other nsaids. severe, rarely fatal, anaphylactic-like reactions to nsaids have been reported in such patients (see warnings, anaph

DICLOFENAC SODIUM tablet, extended release Vereinigte Staaten - Englisch - NLM (National Library of Medicine)

diclofenac sodium tablet, extended release

physicians total care, inc. - diclofenac sodium (unii: qtg126297q) (diclofenac - unii:144o8ql0l1) - diclofenac sodium 100 mg - carefully consider the potential benefits and risks of diclofenac sodium extended-release and other treatment options before deciding to use diclofenac sodium extended-release. use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see warnings). diclofenac sodium extended-release tablets are indicated: • for relief of signs and symptoms of osteoarthritis • for relief of signs and symptoms of rheumatoid arthritis diclofenac sodium extended-release tablets are contraindicated in patients with known hypersensitivity to diclofenac. diclofenac sodium extended-release should not be given to patients who have experienced asthma, urticaria, or other allergic-type reactions after taking aspirin or other nsaids. severe, rarely fatal, anaphylactic-like reactions to nsaids have been reported in such patients (see warnings, anaphylactoid reactions, and precautions, preexisting asthma). diclofenac sodium extended-release is contraindicated for the treatment of

IBUPROFEN tablet Vereinigte Staaten - Englisch - NLM (National Library of Medicine)

ibuprofen tablet

ascend laboratories, llc - ibuprofen (unii: wk2xyi10qm) (ibuprofen - unii:wk2xyi10qm) - carefully consider the potential benefits and risks of ibuprofen tablets and other treatment options before deciding to use ibuprofen tablets. use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see warnings ). ibuprofen tablets are indicated for relief of the signs and symptoms of rheumatoid arthritis and osteoarthritis. ibuprofen tablets are indicated for relief of mild to moderate pain. ibuprofen tablets are also indicated for the treatment of primary dysmenorrhea. controlled clinical trials to establish the safety and effectiveness of ibuprofen tablets in children have not been conducted. ibuprofen tablets are contraindicated in patients with known hypersensitivity to ibuprofen. ibuprofen tablets should not be given to patients who have experienced asthma, urticaria, or allergic-type reactions after taking aspirin or other nsaids. severe, rarely fatal, anaphylactic-like reactions to nsaids have been reported in such patients (see warnings, anaph